Review Focus on Formononetin: Anticancer Potential and Molecular Targets Samantha Kah Ling Ong 1, Muthu K. Shanmugam 1, Lu Fan 1, Sarah E. Fraser 3, Frank Arfuso 4, Kwang Seok Ahn 2,*, Gautam Sethi 1,* and Anupam Bishayee 3,* 1 Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117600, Singapore;
[email protected] (S.K.L.O.);
[email protected] (M.K.S.);
[email protected] (L.F.) 2 Department of Science in Korean Medicine, Kyung Hee University, 24 Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Korea 3 Lake Erie College of Osteopathic Medicine, Bradenton, FL 34211, USA;
[email protected] 4 Stem Cell and Cancer Biology Laboratory, School of Pharmacy and Biomedical Sciences, Curtin Health Innovation Research Institute, Curtin University, Perth, WA 6102, Australia;
[email protected] * Correspondence:
[email protected] (K.S.A.);
[email protected] (G.S.);
[email protected] or
[email protected] (A.B.); Tel.: +82-2-961-2316 (K.S.A.); +65-6516-3267 (G.S.); +1-(941)-782-5950 (A.B.) Fax: +65-6873-7690 (G.S.) Received: 22 March 2019; Accepted: 28 April 2019; Published: 1 May 2019 Abstract: Formononetin, an isoflavone, is extracted from various medicinal plants and herbs, including the red clover (Trifolium pratense) and Chinese medicinal plant Astragalus membranaceus. Formononetin’s antioxidant and neuroprotective effects underscore its therapeutic use against Alzheimer’s disease. Formononetin has been under intense investigation for the past decade as strong evidence on promoting apoptosis and against proliferation suggests for its use as an anticancer agent against diverse cancers.